US Patent 11236111 Hepatitis B antiviral agents
Patent 11236111 was granted and assigned to Enanta Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 3, 2020
0
Date of Patent
February 1, 2022
0
Patent Applicant
Patent Application Number
16891401
0
Patent Citations
Patent Inventor Names
Yat Sun Or
0
Xiaowen Peng
0
Xuri Gao
0
Yao-Ling Qiu
0
Byung-Chul Suh
0
Hui Cao
0
Jiajun Zhang
0
Jorden Kass
0
Wei Li
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11236111 Hepatitis B antiviral agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.